Nanoform awarded GMP certification
Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, has been awarded a Good Manufacturing Practices (GMP) certification by the Finnish Medicines Agency, FIMEA. Achieving GMP status permits Nanoform to manufacture an investigational drug, developed using its proprietaryCESS[® ]nanoparticle engineering platform, for use in clinical trials. The GMP certification represents a very important milestone for Nanoform as it continues to increase the commercial reach of its CESS[®] technology, which reduces the size of API particles to